Industry Primer — Healthcare
Home health and hospice services provide medical and non-medical care in patients' homes, including skilled nursing, physical therapy, hospice/palliative care, personal care assistance, and chronic disease management. The U.S. home health market exceeds $130 billion annually, with hospice representing roughly $25 billion. The sector is highly fragmented with over 11,000 Medicare-certified home health agencies and 5,000+ hospice providers. Public companies include Ensign Group, Addus HomeCare, Amedisys, and Chemed (VITAS hospice). The sector benefits from the structural shift toward lower-cost care settings and the aging population's preference to receive care at home.
The near-term environment reflects regulatory transition. CMS implemented a new Patient-Driven Groupings Model (PDGM) that shifted reimbursement toward clinical acuity, benefiting providers with sicker patient populations. Home health faces continued Medicare rate pressures with proposed cuts that industry is actively challenging. Hospice fundamentals remain strong with live discharge rates stabilizing and average length of stay improving. Labor challenges persist, particularly for home health aides, though wage inflation has moderated from 2022 peaks.
The five-year outlook is favorable driven by the hospital-at-home movement, Medicare Advantage growth (MA plans prefer home-based care economics), and value-based payment models that reward home health utilization. Technology-enabled remote monitoring will expand the acuity range treatable at home. Consolidation will continue as scale provides advantages in labor recruitment, technology investment, and payer contracting. Expect the sector to grow 7-10% annually, outpacing broader healthcare.
Long-term demographics are powerfully favorable. The 80+ population — the highest utilizers of home health and hospice — will nearly double by 2040. Institutional capacity (nursing homes, hospitals) cannot expand fast enough to meet demand, making home-based care delivery essential. Advanced remote monitoring, wearable sensors, and AI-powered clinical oversight will enable increasingly complex care at home. The key risk is sustained Medicare reimbursement pressure as home health volumes grow.
Medicare reimbursement rates and payment model design are the dominant economic driver. Labor availability and cost for nurses, therapists, and aides directly determines service capacity and margins. Referral relationships with hospitals, physicians, and health plans drive patient volume. Regulatory compliance costs are significant — home health is among the most surveyed healthcare segments. Geographic concentration enables efficient routing and scheduling, reducing per-visit costs.
AI enables substantial transformation. Remote patient monitoring with AI-powered anomaly detection can identify clinical deterioration 12-24 hours before traditional assessment, reducing emergency hospitalizations. Natural language processing automates clinical documentation, saving nurses 30-45 minutes per shift. Predictive models optimize visit scheduling and routing, improving clinician productivity by 15-20%. AI-driven care planning tools match patients to appropriate services and predict hospice eligibility, improving transition timing.
Home health and hospice providers can implement remote patient monitoring technology that extends clinician reach and enables earlier intervention on patient deterioration — improving outcomes and supporting higher-acuity patients at home. AI-powered visit scheduling and routing tools optimize clinician travel time, improving productivity and reducing mileage costs. Electronic documentation platforms with clinical decision support improve compliance and reduce claim denials. Predictive analytics on patient acuity support more accurate staffing models.
Ensign Group (ENSG) operates skilled nursing and home health across multiple states. Addus HomeCare (ADUS) focuses on personal care and home health services. Chemed (CHE) operates VITAS, the largest hospice provider. Amedisys (AMED) provides home health, hospice, and personal care. Pennant Group (PNTG) was spun from Ensign and operates home health and hospice agencies. Brookdale Senior Living (BKD) combines senior living with home health services.